Publication Information

{'id': 'https://openalex.org/W2103511358', 'doi': 'https://doi.org/10.1016/j.ejmech.2006.11.014', 'title': 'Synthesis of novel diarylpyrimidine analogues of TMC278 and their antiviral activity against HIV-1 wild-type and mutant strains', 'display_name': 'Synthesis of novel diarylpyrimidine analogues of TMC278 and their antiviral activity against HIV-1 wild-type and mutant strains', 'publication_year': 2006, 'publication_date': '2006-12-16', 'ids': {'openalex': 'https://openalex.org/W2103511358', 'doi': 'https://doi.org/10.1016/j.ejmech.2006.11.014', 'mag': '2103511358', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/17223230'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.ejmech.2006.11.014', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4210169613', 'display_name': 'European Journal of Medicinal Chemistry', 'issn_l': '0223-5234', 'issn': ['0223-5234', '1768-3254'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5057657064', 'display_name': 'Céline Mordant', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210092212', 'display_name': 'Johnson & Johnson (France)', 'ror': 'https://ror.org/00gfjrf11', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I4210092212']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Céline Mordant', 'raw_affiliation_strings': ['Johnson & Johnson Pharmaceutical Research and Development, Medicinal Chemistry Department, Campus de Maigremont BP315, F-27106 Val de Reuil Cedex, France.'], 'affiliations': [{'raw_affiliation_string': 'Johnson & Johnson Pharmaceutical Research and Development, Medicinal Chemistry Department, Campus de Maigremont BP315, F-27106 Val de Reuil Cedex, France.', 'institution_ids': ['https://openalex.org/I4210092212']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5083391587', 'display_name': 'Benoît Schmitt', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210092212', 'display_name': 'Johnson & Johnson (France)', 'ror': 'https://ror.org/00gfjrf11', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I4210092212']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Benoit Schmitt', 'raw_affiliation_strings': ['Johnson & Johnson Pharmaceutical Research and Development, Medicinal Chemistry Department, Campus de Maigremont BP315, F-27106 Val de Reuil Cedex, France.'], 'affiliations': [{'raw_affiliation_string': 'Johnson & Johnson Pharmaceutical Research and Development, Medicinal Chemistry Department, Campus de Maigremont BP315, F-27106 Val de Reuil Cedex, France.', 'institution_ids': ['https://openalex.org/I4210092212']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5070086202', 'display_name': 'Élisabeth Pasquier', 'orcid': 'https://orcid.org/0000-0002-5849-0204'}, 'institutions': [{'id': 'https://openalex.org/I4210092212', 'display_name': 'Johnson & Johnson (France)', 'ror': 'https://ror.org/00gfjrf11', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I4210092212']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Elisabeth Pasquier', 'raw_affiliation_strings': ['Johnson & Johnson Pharmaceutical Research and Development, Medicinal Chemistry Department, Campus de Maigremont BP315, F-27106 Val de Reuil Cedex, France.'], 'affiliations': [{'raw_affiliation_string': 'Johnson & Johnson Pharmaceutical Research and Development, Medicinal Chemistry Department, Campus de Maigremont BP315, F-27106 Val de Reuil Cedex, France.', 'institution_ids': ['https://openalex.org/I4210092212']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5064214935', 'display_name': 'Christophe Demestre', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210092212', 'display_name': 'Johnson & Johnson (France)', 'ror': 'https://ror.org/00gfjrf11', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I4210092212']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Christophe Demestre', 'raw_affiliation_strings': ['Johnson & Johnson Pharmaceutical Research and Development, Medicinal Chemistry Department, Campus de Maigremont BP315, F-27106 Val de Reuil Cedex, France.'], 'affiliations': [{'raw_affiliation_string': 'Johnson & Johnson Pharmaceutical Research and Development, Medicinal Chemistry Department, Campus de Maigremont BP315, F-27106 Val de Reuil Cedex, France.', 'institution_ids': ['https://openalex.org/I4210092212']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5050080785', 'display_name': 'Laurence Quéguiner', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210092212', 'display_name': 'Johnson & Johnson (France)', 'ror': 'https://ror.org/00gfjrf11', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I4210092212']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Laurence Queguiner', 'raw_affiliation_strings': ['Johnson & Johnson Pharmaceutical Research and Development, Medicinal Chemistry Department, Campus de Maigremont BP315, F-27106 Val de Reuil Cedex, France.'], 'affiliations': [{'raw_affiliation_string': 'Johnson & Johnson Pharmaceutical Research and Development, Medicinal Chemistry Department, Campus de Maigremont BP315, F-27106 Val de Reuil Cedex, France.', 'institution_ids': ['https://openalex.org/I4210092212']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5016645689', 'display_name': 'Chantal Masungi', 'orcid': None}, 'institutions': [], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Chantal Masungi', 'raw_affiliation_strings': ['Tibotec BVBA, Generaal De Wittelaan L 11B-3, B-2800 Mechelen, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Tibotec BVBA, Generaal De Wittelaan L 11B-3, B-2800 Mechelen, Belgium.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043163465', 'display_name': 'Anik Peeters', 'orcid': None}, 'institutions': [], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Anik Peeters', 'raw_affiliation_strings': ['Tibotec BVBA, Generaal De Wittelaan L 11B-3, B-2800 Mechelen, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Tibotec BVBA, Generaal De Wittelaan L 11B-3, B-2800 Mechelen, Belgium.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5087698273', 'display_name': 'Liesbeth Smeulders', 'orcid': None}, 'institutions': [], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Liesbeth Smeulders', 'raw_affiliation_strings': ['Tibotec BVBA, Generaal De Wittelaan L 11B-3, B-2800 Mechelen, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Tibotec BVBA, Generaal De Wittelaan L 11B-3, B-2800 Mechelen, Belgium.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045216332', 'display_name': 'Eva Bettens', 'orcid': None}, 'institutions': [], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Eva Bettens', 'raw_affiliation_strings': ['Tibotec BVBA, Generaal De Wittelaan L 11B-3, B-2800 Mechelen, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Tibotec BVBA, Generaal De Wittelaan L 11B-3, B-2800 Mechelen, Belgium.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5084135823', 'display_name': 'Kurt Hertogs', 'orcid': None}, 'institutions': [], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Kurt Hertogs', 'raw_affiliation_strings': ['Tibotec BVBA, Generaal De Wittelaan L 11B-3, B-2800 Mechelen, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Tibotec BVBA, Generaal De Wittelaan L 11B-3, B-2800 Mechelen, Belgium.', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5046188438', 'display_name': 'Jan Heeres', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I137982388', 'display_name': 'Janssen (Belgium)', 'ror': 'https://ror.org/04yzcpd71', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I137982388']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Jan Heeres', 'raw_affiliation_strings': ['Center for Molecular Design, Janssen Pharmaceutica, Antwerpsesteenweg 37, B-2350 Vosselaar, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Center for Molecular Design, Janssen Pharmaceutica, Antwerpsesteenweg 37, B-2350 Vosselaar, Belgium.', 'institution_ids': ['https://openalex.org/I137982388']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052131378', 'display_name': 'Paul Lewi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I137982388', 'display_name': 'Janssen (Belgium)', 'ror': 'https://ror.org/04yzcpd71', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I137982388']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'Paul Lewi', 'raw_affiliation_strings': ['Center for Molecular Design, Janssen Pharmaceutica, Antwerpsesteenweg 37, B-2350 Vosselaar, Belgium.'], 'affiliations': [{'raw_affiliation_string': 'Center for Molecular Design, Janssen Pharmaceutica, Antwerpsesteenweg 37, B-2350 Vosselaar, Belgium.', 'institution_ids': ['https://openalex.org/I137982388']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5024441137', 'display_name': 'Jérôme Guillemont', 'orcid': 'https://orcid.org/0000-0002-1766-006X'}, 'institutions': [{'id': 'https://openalex.org/I4210092212', 'display_name': 'Johnson & Johnson (France)', 'ror': 'https://ror.org/00gfjrf11', 'country_code': 'FR', 'type': 'company', 'lineage': ['https://openalex.org/I1330063522', 'https://openalex.org/I4210092212']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Jerome Guillemont', 'raw_affiliation_strings': ['Johnson & Johnson Pharmaceutical Research and Development, Medicinal Chemistry Department, Campus de Maigremont BP315, F-27106 Val de Reuil Cedex, France.'], 'affiliations': [{'raw_affiliation_string': 'Johnson & Johnson Pharmaceutical Research and Development, Medicinal Chemistry Department, Campus de Maigremont BP315, F-27106 Val de Reuil Cedex, France.', 'institution_ids': ['https://openalex.org/I4210092212']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 2, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 4710, 'currency': 'USD', 'value_usd': 4710, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 1.963, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 69, 'citation_normalized_percentile': {'value': 0.829785, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 95, 'max': 96}, 'biblio': {'volume': '42', 'issue': '5', 'first_page': '567', 'last_page': '579'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10526', 'display_name': 'HIV/AIDS drug development and treatment', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2725', 'display_name': 'Infectious Diseases'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10112', 'display_name': 'HIV Research and Treatment', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2406', 'display_name': 'Virology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12827', 'display_name': 'Biochemical and Molecular Research', 'score': 0.9976, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/nevirapine', 'display_name': 'Nevirapine', 'score': 0.9177034}, {'id': 'https://openalex.org/keywords/efavirenz', 'display_name': 'Efavirenz', 'score': 0.8532796}, {'id': 'https://openalex.org/keywords/wild-type', 'display_name': 'Wild type', 'score': 0.55302536}, {'id': 'https://openalex.org/keywords/reverse-transcriptase-inhibitor', 'display_name': 'Reverse-transcriptase inhibitor', 'score': 0.527675}], 'concepts': [{'id': 'https://openalex.org/C2779130552', 'wikidata': 'https://www.wikidata.org/wiki/Q263713', 'display_name': 'Nevirapine', 'level': 5, 'score': 0.9177034}, {'id': 'https://openalex.org/C2781432083', 'wikidata': 'https://www.wikidata.org/wiki/Q422645', 'display_name': 'Efavirenz', 'level': 5, 'score': 0.8532796}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.8307502}, {'id': 'https://openalex.org/C143065580', 'wikidata': 'https://www.wikidata.org/wiki/Q3285695', 'display_name': 'Mutant', 'level': 3, 'score': 0.74160475}, {'id': 'https://openalex.org/C156719811', 'wikidata': 'https://www.wikidata.org/wiki/Q28774', 'display_name': 'Reverse transcriptase', 'level': 4, 'score': 0.70982695}, {'id': 'https://openalex.org/C207583985', 'wikidata': 'https://www.wikidata.org/wiki/Q128723', 'display_name': 'Wild type', 'level': 4, 'score': 0.55302536}, {'id': 'https://openalex.org/C2777351918', 'wikidata': 'https://www.wikidata.org/wiki/Q421559', 'display_name': 'Reverse-transcriptase inhibitor', 'level': 5, 'score': 0.527675}, {'id': 'https://openalex.org/C2909970146', 'wikidata': 'https://www.wikidata.org/wiki/Q421559', 'display_name': 'Nucleoside Reverse Transcriptase Inhibitor', 'level': 5, 'score': 0.50851285}, {'id': 'https://openalex.org/C71240020', 'wikidata': 'https://www.wikidata.org/wiki/Q186011', 'display_name': 'Stereochemistry', 'level': 1, 'score': 0.50750226}, {'id': 'https://openalex.org/C3013748606', 'wikidata': 'https://www.wikidata.org/wiki/Q15787', 'display_name': 'Human immunodeficiency virus (HIV)', 'level': 2, 'score': 0.48919204}, {'id': 'https://openalex.org/C159047783', 'wikidata': 'https://www.wikidata.org/wiki/Q7215', 'display_name': 'Virology', 'level': 1, 'score': 0.47426903}, {'id': 'https://openalex.org/C114373084', 'wikidata': 'https://www.wikidata.org/wiki/Q273499', 'display_name': 'Chemical synthesis', 'level': 3, 'score': 0.46341294}, {'id': 'https://openalex.org/C2776543447', 'wikidata': 'https://www.wikidata.org/wiki/Q28734', 'display_name': 'Nucleoside', 'level': 2, 'score': 0.41800398}, {'id': 'https://openalex.org/C202751555', 'wikidata': 'https://www.wikidata.org/wiki/Q221681', 'display_name': 'In vitro', 'level': 2, 'score': 0.3337986}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.15773928}, {'id': 'https://openalex.org/C67705224', 'wikidata': 'https://www.wikidata.org/wiki/Q11053', 'display_name': 'RNA', 'level': 3, 'score': 0.13282046}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.10187483}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.06507689}, {'id': 'https://openalex.org/C2993143319', 'wikidata': 'https://www.wikidata.org/wiki/Q583050', 'display_name': 'Antiretroviral therapy', 'level': 4, 'score': 0.06342369}, {'id': 'https://openalex.org/C142462285', 'wikidata': 'https://www.wikidata.org/wiki/Q2528140', 'display_name': 'Viral load', 'level': 3, 'score': 0.0593988}], 'mesh': [{'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': True}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000737', 'qualifier_name': 'chemistry', 'is_major_topic': True}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002851', 'descriptor_name': 'Chromatography, High Pressure Liquid', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004285', 'descriptor_name': 'Dogs', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015497', 'descriptor_name': 'HIV-1', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009682', 'descriptor_name': 'Magnetic Resonance Spectroscopy', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013058', 'descriptor_name': 'Mass Spectrometry', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009570', 'descriptor_name': 'Nitriles', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': 'Q000138', 'qualifier_name': 'chemical synthesis', 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051381', 'descriptor_name': 'Rats', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017208', 'descriptor_name': 'Rats, Wistar', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018894', 'descriptor_name': 'Reverse Transcriptase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068696', 'descriptor_name': 'Rilpivirine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D013056', 'descriptor_name': 'Spectrophotometry, Ultraviolet', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1016/j.ejmech.2006.11.014', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4210169613', 'display_name': 'European Journal of Medicinal Chemistry', 'issn_l': '0223-5234', 'issn': ['0223-5234', '1768-3254'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/17223230', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.83}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 16, 'referenced_works': ['https://openalex.org/W1576999979', 'https://openalex.org/W1969304309', 'https://openalex.org/W2035126479', 'https://openalex.org/W2055542167', 'https://openalex.org/W2061963645', 'https://openalex.org/W2063089952', 'https://openalex.org/W2088559179', 'https://openalex.org/W2109193129', 'https://openalex.org/W2109893413', 'https://openalex.org/W2117784959', 'https://openalex.org/W2119181700', 'https://openalex.org/W2143910776', 'https://openalex.org/W2159788532', 'https://openalex.org/W2161558889', 'https://openalex.org/W2172130850', 'https://openalex.org/W72974347'], 'related_works': ['https://openalex.org/W3155579397', 'https://openalex.org/W2166878266', 'https://openalex.org/W2140561708', 'https://openalex.org/W2140384375', 'https://openalex.org/W2096600825', 'https://openalex.org/W2044225274', 'https://openalex.org/W2043953605', 'https://openalex.org/W2014257673', 'https://openalex.org/W178626500', 'https://openalex.org/W1785188379'], 'abstract_inverted_index': None, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2103511358', 'counts_by_year': [{'year': 2023, 'cited_by_count': 3}, {'year': 2022, 'cited_by_count': 2}, {'year': 2021, 'cited_by_count': 2}, {'year': 2020, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 5}, {'year': 2017, 'cited_by_count': 2}, {'year': 2016, 'cited_by_count': 5}, {'year': 2014, 'cited_by_count': 6}, {'year': 2013, 'cited_by_count': 6}, {'year': 2012, 'cited_by_count': 8}], 'updated_date': '2025-01-05T03:53:49.528522', 'created_date': '2016-06-24'}